26295-56-7

26295-56-7 structure

Name: N-Trifluoroacetyldoxorubicin
Chemical Name: N-Trifluoroacetyldoxorubicin
CAS Number: 26295-56-7
Molecular Formula: C₂₉H₂₈F₃NO₁₂
Molecular Weight: 639.52700
Create Date: 2017-10-11 08:46:05
Modify Date: 2024-01-11 11:55:57
N-Trifluoroacetyladriamycin is a metabolite of valrubicin. Valrubicin (N-trifluoroacetyladriamycin-14-valerate, trade name Valstar) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder. It was originally launched as Valstar in the U.S.

Name	N-Trifluoroacetyldoxorubicin
Synonyms	5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-.α.-L-lyxo-hexopyranosyl]oxy]-, (8S-cis)-

CHEMICAL NAME :: 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-(( 2,3,6-trideoxy- 3-(trifluoroacetamido)-alpha-L-lyxo-hexopyranosyl)oxy )-6,8,11-trihydroxy-, (8S-cis)-

WISWESSER LINE NOTATION :: L E6 C666 BV MVT&&&J DQ HV1Q HQ KQ RO1 FO- FT6OTJ B1 CQ DMVXFFF

REFERENCE :: CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 41,1006,1981

383-64-2

25316-40-9

~86%

26295-56-7

Literature: Acton; Tong Journal of Medicinal Chemistry, 1981 , vol. 24, # 6 p. 669 - 673

25316-40-9

407-25-0

~88%

26295-56-7

Literature: Zhang, Yifei; Dai, Yang; Hou, Miao; Li, Tian; Ge, Jun; Liu, Zheng RSC Advances, 2013 , vol. 3, # 45 p. 22963 - 22966

23214-92-8

~82%

26295-56-7

Literature: Berube; Richardson; Ford Synthetic Communications, 1991 , vol. 21, # 7 p. 931 - 944

23214-92-8

383-63-1

~82%

26295-56-7

Literature: Berube; Lepage Synthetic Communications, 1998 , vol. 28, # 6 p. 1109 - 1116